Angina Pectoris

• FDA approval · 2020-07-06
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Eugia US LLC)

  FDA approves Verapamil hydrochloride as an original application generic; the product is used to treat hypertension, angina, and certain arrh…

• FDA approval · 2020-05-14
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Somerset Therapeutics, LLC)

  FDA approved a supplemental application for verapamil hydrochloride, a generic version, filed by Somerset Therapeutics, LLC.

• FDA approval · 2020-05-12
  FDA Approved: ISOSORBIDE DINITRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved a supplemental application for Isosorbide Dinitrate from Hikma Pharmaceuticals USA Inc., marking an approved modification t…

• FDA approval · 2020-04-29
  FDA Approved: RANOLAZINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for Ranolazine (ANDA 211707), approving a generic Ranolazine pro…

• FDA approval · 2020-04-29
  FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved Teva's supplemental application for diltiazem hydrochloride (generic) under ANDA074185.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2020-04-28
  FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Accord Healthcare, Inc.)

  FDA approved Accord Healthcare's diltiazem hydrochloride as an original generic application (ANDA) for the established indications of diltia…

• FDA approval · 2020-03-31
  FDA Approved: METOPROLOL SUCCINATE — Original Application (Nivagen Pharmaceuticals, Inc.)

  FDA approved an original ANDA for metoprolol succinate, a generic product manufactured by Nivagen Pharmaceuticals, Inc.

• FDA approval · 2020-03-27
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)

  FDA approved a supplemental application for verapamil hydrochloride from Nivagen Pharmaceuticals, Inc., updating regulatory status for this …

• FDA approval · 2020-03-25
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Caplin Steriles Limited)

  FDA approves Caplin Steriles Limited's Verapamil Hydrochloride under an Original Application (ANDA). This confirms the availability of a gen…

• FDA approval · 2020-02-27
  FDA Approved: RANOLAZINE — Original Application (Micro Labs Limited)

  FDA approved the original application for ranolazine from Micro Labs Limited, enabling generic access to this antianginal medication.

• FDA approval · 2020-02-20
  FDA Approved: ISOSORBIDE DINITRATE — Supplemental Application (Sandoz Inc.)

  The FDA approved a supplemental application for Isosorbide Dinitrate from Sandoz Inc., indicating regulatory approval of a change to the pro…

• FDA approval · 2020-02-20
  FDA Approved: ISOSORBIDE DINITRATE — Supplemental Application (Sandoz Inc.)

  FDA approved a supplemental application for Sandoz Inc. to update/expand the approval of the generic isosorbide dinitrate.

• FDA approval · 2020-02-12
  FDA Approved: RANOLAZINE — Original Application (Lifestar Pharma LLC)

  FDA approved the original ANDA for Ranolazine from Lifestar Pharma LLC, authorizing a generic version of the anti-anginal medication.

• FDA approval · 2020-01-24
  FDA Approved: RANOLAZINE — Supplemental Application (Radha Pharmaceuticals, Inc)

  The FDA approved a supplemental application for Ranolazine from Radha Pharmaceuticals, Inc. This is a modification to the previously approve…

• FDA approval · 2020-01-22
  FDA Approved: RANOLAZINE — Supplemental Application (Viona Pharmaceuticals Inc)

  FDA approved a supplemental application for ranolazine filed by Viona Pharmaceuticals Inc (ANDA 210188). This action completes an additional…

• FDA approval · 2020-01-06
  FDA Approved: PROPRANOLOL HYDROCHLORIDE — Original Application (Lannett Company, Inc.)

  FDA approved the original application for propranolol hydrochloride from Lannett Company, Inc., enabling a generic version to be marketed.

• FDA approval · 2019-12-19
  FDA Approved: CONJUPRI — Original Application (CSPC Ouyi Pharmaceutical Co. Ltd)

  FDA approved CONJUPRI (levamlodipine) through an Original Application by CSPC Ouyi Pharmaceutical Co. Ltd for indications including hyperten…

• FDA approval · 2019-11-21
  FDA Approved: ATENOLOL — Original Application (Unichem Pharmaceuticals (USA), Inc.)

  FDA approved atenolol as a generic drug under an Original Application (ANDA) from Unichem Pharmaceuticals (USA), Inc.

• FDA approval · 2019-11-20
  FDA Approved: ISOSORBIDE DINITRATE — Original Application (BluePoint Laboratories)

  FDA approved the original application for a generic Isosorbide Dinitrate product from BluePoint Laboratories.

• FDA approval · 2019-10-31
  FDA Approved: RANOLAZINE — Supplemental Application (Ajanta Pharma USA Inc.)

  FDA approved a supplemental application for ranolazine by Ajanta Pharma USA Inc.

• FDA approval · 2019-10-30
  FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)

  FDA approved a supplemental application for metoprolol tartrate by Hospira, Inc. under ANDA 078085, finalizing changes to the generic produc…

• FDA approval · 2019-10-24
  FDA Approved: METOPROLOL — Supplemental Application (Baxter Healthcare Corporation)

  The FDA approved Baxter Healthcare Corporation's supplemental application for Metoprolol Tartrate under ANDA 078950. This approval updates a…

• FDA approval · 2019-10-01
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)

  The FDA approved a supplemental application for Verapamil Hydrochloride by Teva Pharmaceuticals Inc., updating the drug’s labeling and appro…

• FDA approval · 2019-09-26
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  The FDA approved a supplemental application for Verapamil Hydrochloride from Glenmark Pharmaceuticals, updating an already approved generic …

• FDA approval · 2019-09-25
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for verapamil hydrochloride (generic) from Nivagen Pharmaceuticals, Inc., authorizing the sale o…